Melinta Therapeutics, LLC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$3.5Mgeneral payments (2019-2025)
$382Kresearch payments (2019-2025)
13,164clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Paula Bokesch | Lexington, MA | Anesthesiology | $243,750.00 |
| Matthew Wikler | San Diego, CA | Infectious Disease | $160,819.58 |
| Jose Vazquez | Augusta, GA | Infectious Disease | $134,888.07 |
| Michael Chianuri | New London, CT | Internal Medicine | $128,400.00 |
| Juan Diaz | Altamonte Springs, FL | Infectious Disease | $121,411.13 |
| Amar Safdar | Houston, TX | Infectious Disease | $114,054.50 |
| Dino Delaportas | Bridgeport, WV | Infectious Disease | $110,863.95 |
| Jeffrey Alexander | Chicago, IL | Foot & Ankle Surgery | $104,067.72 |
| Andrew Dold | Dacula, GA | Infectious Disease | $85,549.49 |
| Stephen Weinroth | Fairfax, VA | Infectious Disease | $68,302.31 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.